Literature DB >> 26414360

Retrospective cohort study of an enhanced recovery programme in oesophageal and gastric cancer surgery.

P A C Gatenby1, C Shaw1, C Hine1, S Scholtes1, M Koutra1, H Andrew1, M Hacking1, W H Allum.   

Abstract

Introduction Enhanced recovery programmes have been established in some areas of elective surgery. This study applied enhanced recovery principles to elective oesophageal and gastric cancer surgery. Methods An enhanced recovery programme for patients undergoing open oesophagogastrectomy, total and subtotal gastrectomy for oesophageal and gastric malignancy was designed. A retrospective cohort study compared length of stay on the critical care unit (CCU), total length of inpatient stay, rates of complications and in-hospital mortality prior to (35 patients) and following (27 patients) implementation. Results In the cohort study, the median total length of stay was reduced by 3 days following oesophagogastrectomy and total gastrectomy. The median length of stay on the CCU remained the same for all patients. The rates of complications and mortality were the same. Conclusions The standardised protocol reduced the median overall length of stay but did not reduce CCU stay. Enhanced recovery principles can be applied to patients undergoing major oesophagogastrectomy and total gastrectomy as long as they have minimal or reversible co-morbidity.

Entities:  

Keywords:  Enhanced recovery; Gastric neoplasms; Oesophageal neoplasms; Perioperative care; Surgical procedures

Mesh:

Year:  2015        PMID: 26414360      PMCID: PMC5210132          DOI: 10.1308/003588415X14181254789880

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  24 in total

1.  Laparoscopic gastric surgery in an enhanced recovery programme.

Authors:  T P Grantcharov; H Kehlet
Journal:  Br J Surg       Date:  2010-10       Impact factor: 6.939

2.  Fast-track surgery for bilateral total knee replacement.

Authors:  H Husted; A Troelsen; K S Otte; B B Kristensen; G Holm; H Kehlet
Journal:  J Bone Joint Surg Br       Date:  2011-03

3.  Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery.

Authors:  Takanobu Yamada; Tsutomu Hayashi; Haruhiko Cho; Takaki Yoshikawa; Hideki Taniguchi; Ryoji Fukushima; Akira Tsuburaya
Journal:  Gastric Cancer       Date:  2011-05-15       Impact factor: 7.370

4.  A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy.

Authors:  G Brodner; E Pogatzki; H Van Aken; H Buerkle; C Goeters; C Schulzki; H Nottberg; N Mertes
Journal:  Anesth Analg       Date:  1998-02       Impact factor: 5.108

5.  Multimodal optimization of surgical care shows beneficial outcome in gastrectomy surgery.

Authors:  Xin-Xin Liu; Zhi-Wei Jiang; Zhi-Ming Wang; Jie-Shou Li
Journal:  JPEN J Parenter Enteral Nutr       Date:  2010 May-Jun       Impact factor: 4.016

6.  Surgical treatments for esophageal cancers.

Authors:  William H Allum; Luigi Bonavina; Stephen D Cassivi; Miguel A Cuesta; Zhao Ming Dong; Valter Nilton Felix; Edgar Figueredo; Piers A C Gatenby; Leonie Haverkamp; Maksat A Ibraev; Mark J Krasna; René Lambert; Rupert Langer; Michael P N Lewis; Katie S Nason; Kevin Parry; Shaun R Preston; Jelle P Ruurda; Lara W Schaheen; Roger P Tatum; Igor N Turkin; Sylvia van der Horst; Donald L van der Peet; Peter C van der Sluis; Richard van Hillegersberg; Justin C R Wormald; Peter C Wu; Barbara M Zonderhuis
Journal:  Ann N Y Acad Sci       Date:  2014-09       Impact factor: 5.691

7.  Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.

Authors:  Donald E Low; Sonia Kunz; Drew Schembre; Henry Otero; Tom Malpass; Alex Hsi; Guobin Song; Richard Hinke; Richard A Kozarek
Journal:  J Gastrointest Surg       Date:  2007-08-31       Impact factor: 3.452

8.  Prospective study of routine contrast radiology after total gastrectomy.

Authors:  P J Lamb; S M Griffin; M V Chandrashekar; D L Richardson; D Karat; N Hayes
Journal:  Br J Surg       Date:  2004-08       Impact factor: 6.939

9.  Fast Track THR: One Hospital's Experience with a 2-Day Length of Stay Protocol for Total Hip Replacement.

Authors:  Lawrence V Gulotta; Douglas E Padgett; Thomas P Sculco; Michael Urban; Stephen Lyman; Bryan J Nestor
Journal:  HSS J       Date:  2011-07-02

10.  Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.

Authors:  Victoria H Coupland; William Allum; Jane M Blazeby; Michael A Mendall; Richard H Hardwick; Karen M Linklater; Henrik Møller; Elizabeth A Davies
Journal:  BMC Cancer       Date:  2012-01-12       Impact factor: 4.430

View more
  5 in total

1.  Is closed thoracic drainage tube necessary for minimally invasive thoracoscopic-esophagectomy?

Authors:  Lei Cai; Yan Li; Wen-Bin Wang; Man Guo; Xiao Lian; Shu-Ao Xiao; Guang-Hui Xu; Xue-Wen Yang; Li Sun; Hong-Wei Zhang
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  The efficacy of clinical pathway in gastric cancer surgery.

Authors:  Ali Güner
Journal:  Turk J Surg       Date:  2020-03-18

3.  Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.

Authors:  Lin Hu; Hong-Lang Li; Wei-Feng Li; Jun-Min Chen; Jian-Tao Yang; Jun-Jing Gu; Lin Xin
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

4.  Enhanced recovery after surgery protocol in oesophageal cancer surgery: Systematic review and meta-analysis.

Authors:  Magdalena Pisarska; Piotr Małczak; Piotr Major; Michał Wysocki; Andrzej Budzyński; Michał Pędziwiatr
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

5.  The Development, Application and Analysis of an Enhanced Recovery Programme for Major Oesophagogastric Resection.

Authors:  Timothy J Underwood; F Noble; N Madhusudan; D Sharland; R Fraser; J Owsley; M Grant; J J Kelly; James P Byrne
Journal:  J Gastrointest Surg       Date:  2017-01-24       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.